证券日报网讯1月19日，百联股份（600827）在互动平台回答投资者提问时表示，公司高度重视投资者 回报与信任，自2016年度至今连续九年实施稳健的分红政策，持续以现金分红回报广大投资者。公司上 市以来经历多轮吸收合并，不同的第三方交易软件对于融资金额的计算口径不同。未来如有股份回购计 划，将会依据相关法律法规及时履行信息披露义务。 ...

格隆汇1月19日丨奥泰生物(688606.SH)公布，公司于2026年1月16日收到公司控股股东、实际控制人、 董事长高飞先生《关于提议杭州奥泰生物技术股份有限公司回购公司股份的函》，并将回购股份全部用 于注销即减少注册资本。回购股份的资金总额不低于人民币10,000万元（含），不超过人民币20,000万 元（含）。 ...

Core Viewpoint - Bang & Olufsen has initiated a share buyback programme to hedge its share-based long-term incentive programmes, which can now be discontinued based on the assessment of current coverage [1]. Group 1: Share Buyback Programme - The share buyback programme is executed in compliance with EU regulations, specifically the EU Commission Regulation No. 596/2014 and the Safe Harbour Regulation [2]. - The company reserves the right to discontinue the share buyback programme at any time under the Safe Harbour Regulation [2]. Group 2: Transaction Information - Details regarding daily transactions and the total number of shares bought back during the programme will be disclosed in a separate announcement [3].

Group 1 - The core viewpoint of the news is that Jingxing Paper (SZ002067) reached its daily limit up, with a price of 5.94 yuan, reflecting a 10% increase and a total market capitalization of 8.761 billion yuan [1] Group 2 - The reasons for the stock surge include the redemption of convertible bonds, share buyback, and capacity expansion. The company has seen its stock price exceed the conversion price by 130% for 15 consecutive trading days, triggering the redemption clause, indicating positive market sentiment towards the company's future [2] - The company announced a significant share buyback plan of 80 million to 150 million yuan, with a buyback price cap of 4 yuan per share, which is above the current market price, signaling management's recognition of the company's value [2] - The second phase of the company's 600,000-ton boxboard project in Malaysia represents a major capacity expansion, aligning with its long-term development strategy. The paper industry has seen some companies issuing price increase notices, suggesting a market recovery, which may have contributed to the stock's performance [2] - Technical indicators show a bullish trend for the stock, with the MACD indicating a potential golden cross and the K-line breaking through short-term moving average resistance, suggesting strong short-term buy signals [2] - There was significant net inflow of funds into the paper sector on the day of the stock surge, with multiple stocks in the sector showing active price movements, indicating a collective positive market response [2]

董事会认为，鉴于集团的业务及财务表现，其股份的交易价格未能充分反映其内在价值。购回股份可望 提升每股盈利及资本回报率，因此符合公司及股东的整体利益，同时亦反映董事会对集团未来发展的信 心。 昆仑能源(00135)涨近3%，截至发稿，涨2.96%，报7.65港元，成交额2580.52万港元。 消息面上，1月16日，昆仑能源发布公告，董事会已议决，其将根据现有购回授权的条款且受限公司将 于2026年举行的股东周年大会上更新购回授权，可能于本公告日期起至公司将于2027年举行的股东周年 大会结束为止期间，不时在公开市场购回最多8659万股股份(相当于截至本公告日期公司已发行股本约 1%)。公司将以现有现金资源拨付股份购回。预期任何购回的股份将于适当时候注销。根据上市规则， 每股股份的实际购回价不得高于紧接每次购回前五个交易日股份平均收市价的5%以上。 ...

董事会认为，鉴于集团的业务及财务表现，其股份的交易价格未能充分反映其内在价值。购回股份可望 提升每股盈利及资本回报率，因此符合公司及股东的整体利益，同时亦反映董事会对集团未来发展的信 心。 消息面上，1月16日，昆仑能源发布公告，董事会已议决，其将根据现有购回授权的条款且受限公司将 于2026年举行的股东周年大会上更新购回授权，可能于本公告日期起至公司将于2027年举行的股东周年 大会结束为止期间，不时在公开市场购回最多8659万股股份(相当于截至本公告日期公司已发行股本约 1%)。公司将以现有现金资源拨付股份购回。预期任何购回的股份将于适当时候注销。根据上市规则， 每股股份的实际购回价不得高于紧接每次购回前五个交易日股份平均收市价的5%以上。 智通财经APP获悉，昆仑能源(00135)涨近3%，截至发稿，涨2.96%，报7.65港元，成交额2580.52万港 元。 ...

Summary of Key Points Core Viewpoint - On January 16, 44 Hong Kong-listed companies conducted share buybacks, totaling 31.23 million shares and an aggregate amount of HKD 426 million [1]. Group 1: Buyback Details - Xiaomi Group-W repurchased 5.90 million shares for HKD 219.14 million, with a highest price of HKD 37.200 and a lowest price of HKD 37.080, bringing its year-to-date buyback total to HKD 1.45972 billion [2]. - Sunny Optical Technology repurchased 1.13 million shares for HKD 74.89 million, with a highest price of HKD 66.600 and a lowest price of HKD 65.900, accumulating a year-to-date buyback total of HKD 457.32 million [2]. - Xiansheng Pharmaceutical repurchased 4.43 million shares for HKD 51.63 million, with a highest price of HKD 11.773 and a lowest price of HKD 11.520, totaling HKD 93.58 million in year-to-date buybacks [2]. Group 2: Ranking by Buyback Amount - The highest buyback amount on January 16 was from Xiaomi Group-W at HKD 219.14 million, followed by Sunny Optical Technology at HKD 74.89 million [1]. - Other notable buybacks included Xiansheng Pharmaceutical and Juzhibio, with significant amounts as well [1]. Group 3: Ranking by Buyback Volume - Xiaomi Group-W led in buyback volume with 5.90 million shares, followed by Dingdang Health with 5.21 million shares and Xiansheng Pharmaceutical with 4.43 million shares [1].

Group 1 - The core stock price of Maide Medical (688310) closed at 16.15 yuan on January 16, 2026, with an increase of 1.57% and a turnover rate of 1.6% [1] - The trading volume was 26,500 shares, with a total transaction amount of 42.5062 million yuan [1] - On January 16, the net inflow of main funds was 3.6203 million yuan, indicating a positive short-term attitude from main investors [2] Group 2 - Maide Medical announced that from December 30, 2025, to January 14, 2026, it repurchased a total of 1,000,061 shares, accounting for 0.6017% of the total share capital, with a total expenditure of 15,918,630.44 yuan [1] - The repurchase price ranged from 15.69 yuan to 16.20 yuan per share, and the total expected repurchase amount is between 20 million yuan and 40 million yuan [1] - As of January 14, 2026, the cumulative repurchased shares reached 3,592,636, representing 2.1614% of the total share capital, indicating that the repurchase process is more than halfway complete [2]

Group 1 - The company, Yum China (09987), announced a share buyback on January 16, 2026, spending HKD 7.7652 million to repurchase 20,600 shares at a price range of HKD 375.2 to 379.4 per share [1] - On the same day, the company also repurchased 63,200 shares for USD 3 million, with a price range of USD 47.06 to 48.18 per share [1] - Additionally, the company issued 694 shares under its long-term incentive plan and canceled 62,300 shares that had been repurchased [1]

Core Viewpoint - Guizhou Moutai has issued a statement warning consumers about fraudulent information circulating online that misuses its name, promoting false business opportunities and applications for purchasing its products at discounted prices [2][8]. Group 1: Fraudulent Activities - The company has identified multiple instances of fake promotional messages claiming to offer direct supply channels and discounted purchasing options for its products, which are misleading and potentially fraudulent [2][8]. - Guizhou Moutai emphasizes that it has not authorized any third party to disseminate such information and is actively cooperating with authorities to investigate these fraudulent activities [8]. Group 2: Share Buyback Program - On January 4, Guizhou Moutai announced its first share buyback, purchasing 87,059 shares at a total cost of approximately 120.1 million yuan, representing 0.0070% of its total share capital [8][9]. - The buyback was part of a broader plan approved on November 28, 2025, with an expected total buyback amount ranging from 1.5 billion yuan to 3 billion yuan, aimed at reducing registered capital and maintaining shareholder value [9][10]. - This marks the second round of share buybacks since the company went public, with the first round occurring from January to August 2025, during which approximately 3.93 million shares were repurchased at a cost of nearly 6 billion yuan [10].